February 20, 2026

Inventiva S.A. (IVA) Stock Analysis: Biotech Breakthroughs with 131% Potential Upside

Inventiva S.A. (IVA), a France-based clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its focus on developing innovative treatments for metabolic and fibrotic diseases. As it stands,..

CureVac N.V. (CVAC) Stock Analysis: Navigating a Transformational Path in Biotechnology

CureVac N.V. (NASDAQ: CVAC), a pioneering entity in the biotechnology sector, has attracted attention with its innovative approach to messenger ribonucleic acid (mRNA) technology. Despite facing significant challenges, this German-based..

Immunome, Inc. (IMNM)

⚠️ No article content returned.

..

Akebia Therapeutics, Inc. (AKBA): Investor Outlook Reveals 289.83% Potential Upside

Investors eyeing opportunities in the healthcare sector might want to turn their attention to Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company with a focus on kidney disease therapeutics. With..

Semler Scientific, Inc. (SMLR) Stock Analysis: Exploring a Potential 258% Upside in the Healthcare Sector

Semler Scientific, Inc. (SMLR) stands out in the healthcare sector with its innovative solutions in the medical devices industry. Known for its flagship product, QuantaFlo, a quick and efficient blood..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a Promising 37.49% Upside in Biotechnology

Theravance Biopharma, Inc. (NASDAQ: TBPH), headquartered in South San Francisco, California, is making waves in the biotechnology sector with its innovative approach to developing and commercializing treatments for chronic and..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A 50.81% Potential Upside in the Biotech Arena

Zenas BioPharma, Inc. (ZBIO) is making waves in the biotechnology sector with a remarkable potential upside of 50.81%, capturing the attention of investors looking for growth opportunities in the healthcare..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Unveiling a 254.77% Potential Upside in Gene Therapy Innovations

MeiraGTx Holdings plc (NASDAQ: MGTX), a trailblazer in the biotechnology sector, is capturing investor interest with its groundbreaking approach to gene therapy. This clinical stage genetics medicines company is at..

Claritev Corporation (CTEV) Stock Analysis: Explore a Potential 145.60% Upside in the Healthcare Data Analytics Sector

Claritev Corporation (NASDAQ: CTEV), a prominent player in the healthcare information services sector, presents a compelling investment opportunity with a forecasted potential upside of 145.60%. Operating at the intersection of..

Butterfly Network, Inc. (BFLY) Stock Analysis: A Potential 65% Upside in the Healthcare Tech Sector

Butterfly Network, Inc. (NASDAQ: BFLY) is making waves in the healthcare sector with its innovative ultrasound imaging solutions. As a medical device company headquartered in Burlington, Massachusetts, Butterfly Network is..

Keros Therapeutics, Inc. (KROS) Investor Outlook: Analyzing a 38.97% Potential Upside in the Biotech Sector

Keros Therapeutics, Inc. (NASDAQ: KROS) is capturing the attention of investors with its substantial potential upside, making it a compelling opportunity in the biotechnology sector. The company, headquartered in Lexington,..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Uncharted Waters with a 25.9% Revenue Growth

Sonida Senior Living, Inc. (SNDA), a key player in the healthcare sector, specifically within the medical care facilities industry, is gaining attention as it navigates the dynamic landscape of senior..

Eton Pharmaceuticals, Inc. (ETON) Investor Outlook: A 64.65% Upside Potential in the Rare Disease Sector

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is capturing investor attention with its compelling position in the niche market of rare disease treatments. With a market capitalization of $488.62 million, Eton operates..

Spyre Therapeutics (SYRE) Stock Analysis: Unveiling a 50% Potential Upside in Biotech

Spyre Therapeutics, Inc. (SYRE) has been making waves in the biotechnology sector with its innovative approach to treating inflammatory bowel disease (IBD). Listed on the [Exchange], this Waltham, Massachusetts-based company..

Savara, Inc. (SVRA) Stock Analysis: Biotech Player with an 89% Upside Potential

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical entity specializing in rare respiratory diseases, has caught the attention of investors with a remarkable potential upside of 89.03%. Headquartered in Langhorne, Pennsylvania,..

Definitive Healthcare Corp. (DH) Stock Analysis: Unveiling the 148% Upside Potential

Definitive Healthcare Corp. (NASDAQ: DH), a prominent provider in the healthcare information services industry, is capturing investor attention as it navigates a challenging market environment with a promising upside potential...

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Unveiling a Remarkable 433.98% Potential Upside

Anavex Life Sciences Corp. (NASDAQ: AVXL), a biopharmaceutical company based in New York, is creating waves in the healthcare sector, particularly within the biotechnology industry. Specializing in the development of..

Altimmune, Inc. (ALT) Stock Analysis: Eyeing a Potential 293% Upside in the Biotech Space

Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising pipeline in the biotechnology sector. Headquartered in Gaithersburg, Maryland, Altimmune is at the forefront..

Evolus, Inc. (EOLS) Stock Analysis: A Potential 243% Upside Ignites Investor Interest

Evolus, Inc. (NASDAQ: EOLS) is capturing the attention of savvy investors with its compelling growth potential, despite facing some headwinds in its financial metrics. As a healthcare company operating in..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a Potential 218.97% Upside in the Thriving Telehealth Sector

LifeMD, Inc. (LFMD), a prominent player in the burgeoning telehealth sector, presents an intriguing opportunity for investors seeking exposure to the rapidly evolving healthcare landscape. With a market capitalization of..

Search

Funds

February 20, 2026

Search

Funds

February 20, 2026

FTSE 100

Funds